Last reviewed · How we verify

NCT03893513

Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients

Completed Last updated 18 June 2019
What this trial tests

trial testing Transthoracic Electrical Bioimpedance in Hemodynamic Monitoring in 50 participants. Completed in 12 May 2019.

Timeline
12 March 2019
Primary endpoint
12 April 2019
12 May 2019

Quick facts

Lead sponsorDita Aditianingsih
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date12 March 2019
Primary completion12 April 2019
Estimated completion12 May 2019
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Dita Aditianingsih

Who can join

Adults 18 to 80, any sex, with Hemodynamic Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hemodynamics monitoring using non-invasive transthoracic electrical bioimpedance ICON are compatible with standard invasive monitoring using pulse contour analysis EV1000

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of Bioimpedance Versus Pulse Contour Analysis for Intraoperative Cardiac Index Monitoring in Patients Undergoing Kidney Transplantation.
    Aditianingsih D, Hidayat J, Ginting VM. · · 2021 · PMID 35075410 · DOI 10.5812/aapm.117918

Verify or expand the search:

Other recruiting trials for Hemodynamic Monitoring

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03893513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing